利伐沙班

中文名：CS-273;5-氯-N-(((5S)-2-氧代-3-(4-(3-氧代吗啉-4-基)苯基)-1,3-恶唑啉-5-基)甲基)噻吩-2-甲酰胺;利伐沙班;5-氯-N-[[(5S)-2-氧代-3-[4-(3-氧代-4-吗啉基)苯基]-5-恶唑基]甲基]-2-噻吩甲酰胺;利伐沙班, 5-氯-N-(((5S)-2-氧代-3-(4-(3-氧代吗啉-4-基)苯基)-1,3-恶唑啉-5-基)甲基)噻吩-2-甲酰胺;利伐沙班-D4;366789-02-8;利伐沙班标准品；

英文名：Rivaroxaban;5-Chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide;2-Thiophenecarboxamide, 5-chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl];Xarelto;(S)-5-chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)thiophene-2-carboxamide;Rivaroxaban (BAY59-7939);BAY 59-7939 (Rivaroxaban);Rivarobaxan

类别：新药及仿制药-;对照品-杂质对照品;原料药;科研试剂;医药类别;利伐沙班;医药中间体;其他科研原料药;利伐沙班中间体;医药原料;中间体;小分子抑制剂;医药原料药;代谢;小分子抑制剂，天然产物;抗血栓药物;恶唑啉;噻吩;含硫化合物,酰卤;-;Inhibitors;抗凝药;医药化工原料;Chiral Reagents;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals;Sulfur & Selenium Compounds;API;Inhibitor;Rivaroxaban;Pharmaceutical raw materials